After Ranbaxy, Actavis under FDA lens (rediff.com)
The US Congressional committee, which is inquiring into the country's Food and Drug Administration's handling of drug-marketing approvals of India's leading drug-maker Ranbaxy, has extended its probe into similar permissions given to Iceland's Actavis.

Acusphere's Imagify(TM) to be Reviewed at FDA Advisory Committee Meeting on December 10, 2008 (Business Wire via Yahoo! Finance)
WATERTOWN, Mass.----Acusphere, Inc. announced today that the Food and Drug Administration has published a Federal Register Notice on the FDA website of a planned public meeting of the Cardiovascular and Renal Drugs Advisory Committee on December 10, 2008.